PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Sign in See plans ↓
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
✗ Search by company or clause
✗ Video walkthroughs
✗ Podcast episodes
✗ MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
All (1752) Social Media & Digital (720) HCP Hospitality & Meetings (431) Data & Publications (321) Off-label Promotion (219) Patient Organisations (44) Transfers of Value (9) Promotional Material (4) Samples & Gifts (2)
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
Showing 720 results · Social Media & Digital  · Clear
🔒 Subscribers only
AUTH/3866/12/23
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Merck Serono
A health professional complained about frequent emails (said ~every 4 days) from a third-party medical publisher, paid for by Merck Serono, promoting Bavencio (avelumab).Emails used subject lines f…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3860/12/23
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Novartis
An anonymous UK doctor complained about a promotional email for Pluvicto sent by a third-party medical publisher on behalf of Novartis Global.The email’s sender/subject line did not make clear it…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3861/12/23
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Novartis
A UK doctor received a third-party medical publisher email (21 Nov 2023) with the subject “ESMO 2023: Prostate Cancer Update”, implying an unbiased conference update.The email’s “Watch now�…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3845/11/23
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
GSK breach upheld on taskforce website
An anonymous complainant alleged GSK funded a patient organisation to support a therapy-area taskforce, but the taskforce website and related materials did not clearly declare GSK’s support “fr…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3737/2/23
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk breached ABPI Code over Saxenda leavepiece
A health professional complained about a Saxenda (liraglutide) promotional leavepiece (UK20SX00030), described as an “HCP discussion guide”. The complainant alleged the leavepiece was freely av…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3738/2/23
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk
Novo Nordisk made a voluntary admission after an internal investigation linked to Case AUTH/3711/11/22.The issue concerned a weight management and obesity “hub” hosted on a named UK pharmacists…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3869/12/23
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Eli Lilly
A complainant (a doctor) saw a paid “Sponsored” Facebook advertisement from a medical publisher titled “Treating High-Risk Early BC”, which also appeared repeatedly and later on Instagram. …
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3613/2/22
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
AstraZeneca
A complaint was made alleging promotion on LinkedIn.The complaint also alleged a breach of an undertaking.The PMCPA concluded the matter was outwith the scope of the ABPI Code.
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3702/10/22
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Amgen
A health professional complained about an email invitation (sent by a named independent organisation) promoting a webinar and offering a downloadable infographic, both sponsored by Amgen.The email …
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3687/8/22
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
AstraZeneca
An ex-employee complained about UK employees’ engagement with a LinkedIn post authored by an AstraZeneca US employee about FDA approval in metastatic non-small cell lung cancer (NSCLC), linking t…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3675/7/22
Social Media & Digital Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Novartis breached ABPI Code over Jakavi webpage claim implying statistically significant survival be
An anonymous (initially contactable) health professional complained about promotional claims on the Jakavi (ruxolitinib phosphate) webpage on the Novartis UK health professional website.The webpage…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3714/11/22
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GlaxoSmithKline
An anonymous, contactable complainant (a health professional) challenged a headline claim on GlaxoSmithKline UK Limited’s HCP promotional website for Trelegy Ellipta (material code: PM-GB-FVU-WCN…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3677/7/22
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi Sankyo
An anonymous, contactable health professional complained about promotion of Nilemdo (bempedoic acid) and Nustendi (bempedoic acid/ezetimibe). Concern: representatives used sales aids and hard-copy …
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3691/9/22
Social Media & Digital Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
GSK and a Daily Mail Shingrix article
A member of the public complained about a Daily Mail Online article (19 Feb 2022) that named Shingrix and described it in highly positive terms, including comparisons with the NHS-offered vaccine.T…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3700/10/22
Social Media & Digital Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
Ethypharm naloxone poster on telephone
A health professional complained about an Ethypharm poster about naloxone displayed on the side of a telephone booth (REF UK-PREN-17; date of preparation February 2021). The poster used prominent…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3713/11/22
Social Media & Digital Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
PMCPA AUTH/3713/11/22
Tillotts asked Dr Falk to withdraw a Budenofalk 3mg capsules digital advertisement (UI 2200023) following inter-company dialogue about an allegedly misleading claim.Inter-company dialogue concluded…
Clauses: 9.1
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3716/11/22
Social Media & Digital Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Ferring Pharmaceuticals
Tillotts and Ferring entered inter-company dialogue about Pentasa promotional material containing incorrect prescribing information for adult acute dosing (division of doses stated as “2–4” r…
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3684/8/22
Social Media & Digital Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Bayer breached ABPI Code after US Kerendia DTC
A contactable complainant (healthcare communications agency employee) complained about a Kerendia (finerenone) banner advertisement appearing on MailOnline (a UK news website with a .co.uk URL).The…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3683/8/22
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
AstraZeneca
An anonymous, contactable complainant (health professional) complained about a Trixeo (formoterol fumarate dihydrate, budesonide, glycopyrronium) prescribing summary card hosted on a named publishe…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3705/11/22
Social Media & Digital Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
AbbVie
An anonymous, contactable complainant challenged dosing information for Rinvoq (upadacitinib) on AbbVie’s UK HCP product website (AbbViePro).The webpage’s ‘Dosing recommendations’ section s…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3707/11/22
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
AstraZeneca
A senior AstraZeneca employee working for the US affiliate posted on their personal LinkedIn about an FDA approval for a new treatment combination for Stage IV (metastatic) NSCLC, with an embedded …
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3676/7/22
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Roche
A whistleblowing complainant raised concerns about Roche’s internal compliance procedures and a patient organisation website that had been supported by a grant (grant dated November 2020).The com…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3710/11/22
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
MSD
A concerned health professional complained about a LinkedIn post (by a senior leader from NHS England) that was ‘liked’ by Merck Sharp & Dohme (MSD) staff based in the UK.The post followed …
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3715/11/22
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GSK
An anonymous, contactable complainant challenged a video on GSK’s UK respiratory promotional website (Trelegy Ellipta site) summarising a GSK ERS 2022 symposium. The video presented results from …
Clauses: NONE
2022 🔒 Subscribe
← Prev 3 4 5 6 7 8 9 Next → Page 6 of 30 — 720 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Most Popular
Team 5
Up to 5 team members
£999
per year (£200/seat)
£200/person — the most cost-effective team option
  • 5 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • New cases added monthly
  • Admin management portal
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews